Advanced Search

Submit Manuscript

Volume 33, No 7, Jul 2023

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 33 Issue 7, July 2023: 562-564

LETTERS TO THE EDITOR

Bacterial coinfections contribute to severe COVID-19 in winter

Hui Fan1,† , Li Zhou2,† , Jingjun Lv3,† , Shimin Yang4,† , Guozhong Chen1,† , Xinjin Liu4,† , Chunyan Han4,† , Xue Tan4 , Shengnan Qian4 , Zegang Wu5 , Shan Yu1 , Ming Guo4 , Chengliang Zhu5,* , Yu Chen4,* , Ke Lan2,4,*

1State Key Laboratory of Virology, Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei, China
2Animal Biosafety Level 3 Laboratory/Institute for Vaccine Research, Wuhan University, Wuhan, Hubei, China
3Department of Emergency, Renmin Hospital, Wuhan University, Wuhan, Hubei, China
4State Key Laboratory of Virology, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China
5Department of Clinical Laboratory, Renmin Hospital, Wuhan University, Wuhan, Hubei, China
These authors contributed equally: Hui Fan, Li Zhou, Jingjun Lv, Shimin Yang, Guozhong Chen, Xinjin Liu, Chunyan Han
Correspondence: Chengliang Zhu(zhuchengliang@whu.edu.cn)Yu Chen(chenyu@whu.edu.cn)Ke Lan(klan@whu.edu.cn)

Dear Editor,

Although most cases of COVID-19 caused by SARS-CoV-2 Omicron variants are mild or asymptomatic worldwide, coinfection with SARS-CoV-2 and other respiratory pathogens may still aggravate the severity of the illness.1,2 The current literature indicates that coinfection with COVID-19 could occur in 3.70%–9.7% of patients.1,3,4 The proportion of bacterial, and other respiratory viral coinfections may range from 3.02% to 9.7% and 5.41% to 6.61%, respectively. However, these studies demonstrated that coinfections with respiratory pathogens are not common. Thus, antibacterial therapy and diagnostic tests are considered to be unnecessary upon admission for most patients hospitalized with COVID-19.3,5



https://doi.org/10.1038/s41422-023-00821-3

FULL TEXT | PDF

Browse 570